On September 17, Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. was invited to participate in the 22nd China-ASEAN Expo held in Nanning, Guangxi. During the event, Unicornshell engaged in in-depth discussions with ASEAN business delegates, while the Chongzuo Media Convergence Center featured a special report on the company's core products. Moving forward, Unicornshell will sign a strategic cooperation agreement with Chongzuo City to jointly advance the upgrading of the green pharmaceutical industry.

On August 29, Abdulla Azizov, First Deputy Minister of Health of Uzbekistan and Director of the Pharmaceutical Industry Development Agency, led a delegation to visit Unicornshell's Beijing Business Center. Accompanying members included Jakhongir Yakubov, Director of the Investment Department, and Azamat Abdinabiev, Assistant to the Director. The visit aimed to deepen exchanges and cooperation between China and Uzbekistan in the pharmaceutical sector, jointly exploring opportunities for industrial upgrading and technology implementation under the Belt and Road framework.

On September 3rd, the office building of Gansu Plant-Based Innovation Technology Co., Ltd., a subsidiary of Shanghai Unicornshell Pharmaceutical Technology Co., Ltd., successfully reached its structural completion, followed by a grand topping-out ceremony. Attendees included representatives from the Shandan Project Company, the supervising unit, and all members of the general contractor. Located in Shandan County, Zhangye City, Gansu Plant-Based Innovation Technology Co., Ltd. is a vital component of Unicornshell's Northwest Industrial Cluster strategy. The successful topping-out of the office building signifies the project's transition from the main construction phase to secondary structures and interior finishing, laying a solid foundation for subsequent production workshop construction and trial production.

On August 29, the production workshop of Heilongjiang Unicornshell Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of Shanghai Unicornshell Pharmaceutical Technology Co., Ltd., successfully reached its structural completion, marking a new phase in the project's development. This milestone represents the first construction project to reach topping-out within Unicornshell's Northeast industrial cluster strategy, carrying significant strategic importance. Phase I of the project is expected to be completed and commence production by the end of 2025.

On August 19, the closing ceremony of the 14th China Innovation and Entrepreneurship Competition (Liaoning Division) was successfully held in Dalian City. Liaoning Unicornshell Pharmaceutical Technology Co., Ltd. won the first prize in the start-up enterprise group of the biomedical industry competition for its innovative strength in the field of plant-based pharmaceutical excipients, and was awarded a certificate and trophy. 

In the field of scientific and technological innovation, Unicornshell has garnered attention through its strength and innovation. On August 11, Liaoning Unicornshell Pharmaceutical Technology Co., Ltd. stood out in the 14th China Innovation and Entrepreneurship Competition, securing first place in the industry category with a high score of 92.22 points, demonstrating the vibrant momentum of Liaoning's biopharmaceutical industry.

Translated with DeepL.com (free version)

On the afternoon of August 9, Utkirjon MUYSINALIYEV, Deputy Governor of Jizzakh Province, Uzbekistan, and Azizjon IBRAGIMOV, Deputy Minister of Investment and Trade of Jizzakh Province, visited Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. for an exchange.

On August 9, Wang Qiang, member of the Standing Committee of the Wuwei Municipal Party Committee and Secretary of the Liangzhou District Party Committee, Xu Junsheng, member of the Standing Committee of the Liangzhou District Party Committee and Executive Deputy District Magistrate, and Li Jingguan, Director of the Liangzhou District Investment Promotion Bureau, visited Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. for research and investigation. Liu Naiyu, Chairman of Quanji Kang, and his management team warmly welcomed the leaders and accompanied them on a tour of the company's exhibition hall and operations and R&D center. During the visit, Chairman Liu Naiyu provided a comprehensive overview of the company's development history, product portfolio, technological innovation strategies, and progress in the construction of national industrial bases.

On July 30, Qiao Yuhua, member of the Standing Committee of the Qingyun County Party Committee and deputy county magistrate of Dezhou City, led a delegation to visit Hebei Kangxin Plant Capsule Co., Ltd., a subsidiary of Shanghai Unicornshell Pharmaceutical Technology Co., for an on-site inspection and discussion. 

On June 6, 2025, Qiqihar City held the 2025 Model Worker and May Day Labor Award Commendation Meeting. Mr. Wang Qiju, General Manager of Heilongjiang Subsidiary of Shanghai Chuanjikang Pharmaceutical Technology Co., Ltd. was awarded the honorary title of “Qiqihar Model Worker”.